1,006K shares changed hands by the end of trading on Friday. Volume was up 203.45% over the stocks average daily volume.
Investors are a little more bearish on shares of Health Insurance Innovations, I of late as evidenced by the change in short interest. The firm realized a rise in short interest from August 15, 2017 to August 31, 2017 of 5.06%. Short shares increased 80,354 over that timeframe. The short-interest ratio decreased to 3.0 and the short interest percentage is 0.14% as of August 31.
Here is a rundown on some insider market activity for Health Insurance Innovations, I (NASDAQ:HIIQ). CEO of HealthPocket, Inc.* Bruce Telkamp let go of 30,000 shares at a price of $26.68 on Tue the 18th. That brings the CEO of HealthPocket, Inc.*’s holdings to $2,374,547 per an SEC filing yesterday. CTO Sheldon Wang sold 4,750 shares at an average price of $25.80 on July 13th. That brings Wang’s holdings to $5,779,226 as recorded in a recent Form 4 SEC filing.
A few notable investment firms have updated their holdings. As of quarter end Dialectic Capital Management, Lp had bought 288 shares growing its stake by 0.1%. The value of the company’s investment in Health Insurance Innovations, I decreased from $4,307,000 to $3,866,000 a change of $441,000 for the reporting period. As of the end of the quarter Summit Partners Public Asset Management, LLC had disposed of a total of 170,000 shares trimming its position 63.0%. The value of the total investment in Health Insurance Innovations, I went from $4,320,000 to $2,350,000 a change of 45.6% quarter over quarter.
Granite Point Capital Management, L.p. augmented its ownership by buying 7,100 shares an increase of 8.8%. Granite Point Capital Management, L.p. claims 87,900 shares valued at $2,066,000. The value of the position overall is up by 59.8%. Ubs Group Ag cut its position by shedding 61,304 shares a decrease of 96.7% from 03/31/2017 to 06/30/2017. Ubs Group Ag now controls 2,066 shares worth $49,000. The total value of its holdings decreased 95.2%.
On June 26 the stock rating was downgraded to “Market Perform” from “Market Perform” in a statement from Raymond James.
In the market the company is trading down from yesterday’s close of 21.8. Shares last traded at $21.40 which is significantly below $30.30, the stock’s 50 day moving average and marginally under the 200 day moving average of $22.93. The 50 day moving average was down $-8.90 or -29.37% and the 200 day average went down by -6.67%.
Health Insurance Innovations, I currently has a P/E ratio of 17.31 and the market cap of the company is 266.84M. In the last earnings report the EPS was $1.24 and is expected to be $1.53 for the current year with 12,469,000 shares outstanding. Analysts expect next quarter’s EPS will be $0.37 and the next full year EPS is projected to be $1.83.
Health Insurance Innovations, Inc., launched on October 26, 2012, is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP. The Business’s STM plans are provided up to six months, 11 months, or 364 days of health insurance coverage with a range of deductible and copay levels. Individual major medical (IMM) plans cover prescription drugs, pre-existing conditions and preventive care, while STM plans provide optional coverage for prescription drugs. Its hospital indemnity plans provide individuals with a daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits..